Joint sales of electronic medical record and laboratory information systems and blood collection tube preparation equipment
First written in FY2016. 15 of 18 entries say "Restated". Latest entry: FY2026-H1.
The whole theme swung hardest in 2017: 1 of 7 companies on the "Worse" side.
3 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「Against this backdrop, the company continued proposing value-added solutions that contribute to greater efficiency in testing operations at each facility, pursuing further value enhancement for its core blood collection tube preparation systems and related systems.」
The company continues to propose value-added solutions for blood collection tube preparation systems and related systems that contribute to more efficient testing operations. No new specific milestone was indicated regarding integration with electronic medical record or other systems. - FY2025-H1RestatedAnnual report
「Against this backdrop, the company assembled a diverse lineup of its core blood collection tube preparation systems and related systems, ranging from compact desktop models to large systems for large-scale facilities, with the aim of providing an optimal solution for each facility.」
The company continues to provide optimal solutions for each facility by leveraging a lineup of blood collection tube preparation systems and related systems ranging from compact to large models. No new specific milestone was indicated for joint sales with electronic medical record or other systems. - FY2024AdvancedAnnual report
「Against this backdrop, the company expanded the lineup of its core blood collection tube preparation systems and related systems, including by providing new, efficient solutions.」
The company stated that it had provided new, efficient solutions and expanded the lineup of blood collection tube preparation systems and related systems. Improved convenience through cloud use was also cited as a factor driving growth in sales opportunities. - FY2024-Q2RestatedAnnual report
「Against this operating backdrop, we further strengthened R&D activities related to our core blood collection tube preparation equipment and associated systems, worked to enhance the solutions we can provide, expanded sales of compact, high-performance new specimen testing equipment, and continued efforts to ensure a stable supply of consumables and other products.」
The company continues to expand its solutions for blood collection tube preparation systems and related systems, propose the introduction and sale of laboratory analyzers, and ensure a stable supply of consumables. No new specific milestone was indicated for joint sales with electronic medical record or other systems. - FY2024-Q1RestatedAnnual report
「Against this operating backdrop, we further strengthened R&D activities related to our core blood collection tube preparation equipment and associated systems, worked to enhance the solutions we can provide, expanded sales of compact, high-performance new specimen testing equipment, and continued efforts to ensure a stable supply of consumables and other products.」
The company continues to enhance the solutions it can provide and pursue sales activities for blood collection tube preparation systems and related systems. No new specific milestone was indicated for joint sales with electronic medical record or other systems. - FY2023RestatedAnnual report
「Against this backdrop, the company continued to focus on sales activities for blood collection tube preparation systems and related systems that contribute to the efficient operation of healthcare facilities, expanding the range of solutions it can provide in response to requests from healthcare professionals, and continued proposing the new introduction of laboratory analyzers and working to ensure a stable supply of consumables and other products.」
The company continues to expand its solutions for blood collection tube preparation systems and related systems, propose the introduction of laboratory analyzers, and ensure a stable supply of related consumables. - FY2023-Q3RestatedAnnual report
「Against this backdrop, the company continued to focus on sales activities for blood collection tube preparation systems and related systems that contribute to the stable and efficient operation of healthcare facilities, while expanding the range of solutions it can provide, and continued proposing the introduction of laboratory analyzers and working to ensure a stable supply of consumables and other products.」
The company continues to expand its solutions for blood collection tube preparation systems and related systems, propose the introduction of laboratory analyzers, and ensure a stable supply of consumables and other products. No new specific milestone for joint sales was indicated. - FY2023-Q2RestatedAnnual report
「Against this backdrop, the company continued to focus on sales activities for blood collection tube preparation systems and related systems that contribute to the stable and efficient operation of healthcare facilities, while expanding the range of solutions it can provide, and continued proposing the introduction of laboratory analyzers and working to ensure a stable supply of consumables.」
The company continues to expand its solutions for blood collection tube preparation systems and related systems, propose the introduction of laboratory analyzers, and ensure a stable supply of consumables. No new specific milestone for joint sales was indicated. - FY2023-Q1RestatedAnnual report
「Against this backdrop, the company continued to focus on sales activities for blood collection tube preparation systems and related systems that contribute to the stable and efficient operation of healthcare facilities, while expanding its equipment lineup and range of systems, and continued proposing the introduction of laboratory analyzers and working to ensure a stable supply of consumables and other products.」
The company continues sales activities supported by an expanded lineup of blood collection tube preparation systems and related systems, as well as proposals for introducing laboratory analyzers. No new specific milestone was indicated for joint sales with electronic medical record or other systems. - FY2022RestatedAnnual report
「Against this backdrop, the company continued proposing the introduction of blood collection tube preparation systems and related systems and laboratory analyzers that contribute to the efficiency and stable operation of healthcare facilities, while continuing to focus on ensuring a stable supply of the consumables used with these products.」
The company continues to propose the introduction of blood collection tube preparation systems, related systems and laboratory analyzers and to ensure a stable supply of related consumables. No new milestone for joint sales was stated. - FY2022-Q2RestatedAnnual report
「Against this backdrop, the company continued proposing the introduction of blood collection tube preparation systems and related systems and laboratory analyzers that contribute to the safe and stable operation of healthcare facilities, while continuing to focus on ensuring a stable supply of the consumables used with these products.」
The company continues to propose the introduction of blood collection tube preparation systems, related systems and laboratory analyzers, and to ensure a stable supply of related consumables. No new specific milestone was indicated for joint sales. - FY2022-Q1RestatedAnnual report
「Against this backdrop, while responding to COVID-19, the company continued proposing the introduction of blood collection tube preparation systems and related systems and laboratory analyzers that contribute to the stable operation of healthcare facilities, while working to ensure a stable supply of the consumables used with these products.」
The company continues to propose the introduction of blood collection tube preparation systems, related systems and laboratory analyzers. No new specific progress was indicated regarding integration with electronic medical records or other systems. - FY2020RestatedAnnual report
「In addition, blood collection tube preparation systems are increasingly being introduced as part of the digitalization of healthcare facility operations, including the adoption of electronic medical records and ordering systems. However, delays have been observed in the introduction by healthcare facilities of higher-level systems that control blood collection tube preparation systems.」
While the digitalization of healthcare facilities and integration with higher-level systems represent sales opportunities, delays in introducing higher-level systems continue to pose a potential risk to the sales plan. - FY2019RestatedAnnual report
「In addition, blood collection tube preparation systems are increasingly being introduced as part of the digitalization of healthcare facility operations, including the adoption of electronic medical records and ordering systems. However, delays have been observed in the introduction by healthcare facilities of higher-level systems that control blood collection tube preparation systems.」
While the digitalization of healthcare facilities represents a sales opportunity, the company continues to state that delays in introducing higher-level systems could affect its sales plan. - FY2018RestatedAnnual report
「In addition, blood collection tube preparation systems are increasingly being introduced as part of the digitalization of healthcare facility operations, including the adoption of electronic medical records and ordering systems. However, delays have been observed in the introduction by healthcare facilities of higher-level systems that control blood collection tube preparation systems.」
While integration with electronic medical records and ordering systems represents a sales opportunity, the company continues to disclose circumstances in which delays in introducing higher-level systems could affect its sales plan. - FY2017WorsenedAnnual report
「Delays have been observed in the introduction by healthcare facilities of higher-level systems that control blood collection tube preparation systems. In addition, as the outsourcing and contracting-out of clinical laboratory operations progresses, healthcare facilities may take longer to select outsourcing providers. Depending on these factors, the company's annual sales plan for blood collection tube preparation systems could be affected.」
While integration with electronic medical records and other higher-level systems represents a sales opportunity, delays in introducing higher-level systems or selecting outsourcing providers have emerged as specific risks that could affect the sales plan. - FY2017-Q2RestatedAnnual report
「We will continue to focus on selling our core blood collection tube preparation equipment and peripheral equipment, for which demand is expected to grow as electronic medical records and ordering systems become more widespread through the digitization of medical facility operations.」
The company continues to pursue its sales policy for blood collection tube preparation systems and peripheral equipment against the backdrop of healthcare facility digitalization. - FY2016First statedAnnual report
「As demand for blood collection tube preparation systems rises alongside the government-led adoption of electronic medical records and ordering systems through the digitalization of healthcare facility operations, the company will actively market new products and work to further expand its market share by selling electronic medical record and laboratory information systems together with blood collection tube preparation systems to support their adoption.」
The company views the digitalization of healthcare facilities as a demand opportunity and aims to drive adoption and expand its market share for blood collection tube preparation systems through joint sales with electronic medical record and laboratory information systems.